Related Experiment Video

Updated: Nov 10, 2025

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

2.2K

Learning From Mistakes: The Role of Phages in Pandemics

Ahlam Alsaadi1, Beatriz Beamud2,3, Maheswaran Easwaran4

  • 1Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.

Frontiers in Microbiology
|April 5, 2021
PubMed

Insights

The rise of multidrug-resistant bacteria, exacerbated by the COVID-19 pandemic, necessitates alternative treatments like phage therapy. Further research is crucial for developing safe and effective phage therapies to combat this global health threat.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Antibiotic misuse fuels the emergence of multidrug-resistant (MDR) bacteria, posing a significant global health threat.
  • The COVID-19 pandemic has intensified the MDR bacteria crisis due to increased antibiotic use in intensive care units for secondary infections.
  • Existing treatments are becoming ineffective, highlighting the urgent need for novel therapeutic strategies.

Purpose of the Study:

  • To explore alternative treatments for multidrug-resistant bacteria.
  • To highlight the potential of phage therapy as a viable alternative to antibiotics.
  • To emphasize the need for further research and regulatory development for phage therapy.

Main Methods:

  • Review of current literature on antibiotic resistance and emerging infectious diseases.
  • Analysis of the role of phage therapy as a potential solution.
  • Discussion of the challenges and requirements for clinical implementation of phage therapy.

Main Results:

  • Multidrug-resistant bacteria represent a growing global health crisis.
  • Phage therapy shows promise as an alternative treatment modality.
  • Significant investment and research are needed to establish safety and efficacy.

Conclusions:

  • Phage therapy offers a promising avenue for combating multidrug-resistant bacteria.
  • Further research, safety protocols, and regulatory frameworks are essential for clinical application.
  • Investing in alternative therapies like phage therapy is critical to prevent future public health emergencies.
Keywords:
antibiotic resistanceemergent pathogenmultidrug-resistant bacteriaphage therapypublic health

More Related Videos

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides07:19

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides

Published on: June 28, 2024

1.3K
Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins09:40

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins

Published on: June 11, 2015

12.5K

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
74.1K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
64.9K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
686
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
365
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
664
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
36.9K